Products
Molecule | Presentation | Status | Therapeutic Area |
Alendronic acid | 70 mg x 2 tablets | MA and Dossier | FOR THE TREATMENT OF BONE DISEASE - BISPHOSPHONATE |
70 mg x 4 tablets | |||
70 mg x 8 tablets | |||
70 mg x 12 tablets | |||
70 mg x 40 tablets | |||
Amoxicillin | 1 g 12 tablets | MA and Dossier | ANTIBACTERIAL FOR SYSTEMIC USE - PENICILLIN |
Amoxicillin and clavulanic acid | 875 + 125 mg tablets and sachets | MA and Dossier | ANTIBACTERIAL FOR SYSTEMIC USE - PENICILLIN IN ASSOCIATION |
Amoxicillin and clavulanic acid | Pediatric sachets | Under development | |
Apixaban | 2,5 mg x 60 film coated tablets | Under registration | ANTITHROMBOTIC DRUGS - |
5 mg x 60 film coated tablets | |||
Atorvastatin | 10 mg x 30 tablets | MA and Dossier | MODIFYING SUBSTANCE OF LIPIDS - HMG-CoA REDUCTASE INHIBITOR - (STATIN) |
20 mg x 30 tablets | |||
30 mg x 28 tablets | |||
40 mg x 30 tablets | |||
60 mg x 28 tablets | |||
80 mg x 30 tablets | |||
Calcium Levofolinate | 7,5 mg x 10 tablets | Dossier submitted | THERAPEUTIC PRODUCT - DETOXIFYING SUBSTANCE FOR ANTINEOPLASTIC TREATMENTS -ANTIDOTE |
4 mg x 30 tablets | |||
Calcium Levofolinate Lyophilized | 25 mg vial | MA and Dossier | THERAPEUTIC PRODUCT - DETOXIFYING SUBSTANCE FOR ANTINEOPLASTIC TREATMENTS -ANTIDOTE |
100 mg vial | |||
175 mg vial | |||
Calcium Levofolinate solution | 25 mg/2,5 ml vial | MA and Dossier | THERAPEUTIC PRODUCT - DETOXIFYING SUBSTANCE FOR ANTINEOPLASTIC TREATMENTS -ANTIDOTE |
50 mg/ 5 ml vial | |||
100 mg/10 ml vial | |||
175 mg/17,5 ml vial | |||
Cefazolina | 1000 mg/4 ml powder and solvent for injectable solution i.m. | MA and Dossier | ANTIBACTERIAL FOR SYSTEMIC USE - CEPHALOSPORINE OF FIRST GENERATION |
Ceftriaxone | 250 mg/ 2 ml - powder and solvent for injectable solution i.m. | MA and Dossier | ANTIBACTERIAL FOR SYSTEMIC USE - THIRD-GENERATION CEPHALOSPORINE |
500 mg/ 2 ml - powder and solvent for injectable solution i.m. | |||
1 gr/3,5 ml - powder and solvent for injectable solution i.m. | |||
1 g / 10 ml powder and solvent for injectabble solution e.v. | |||
2 g powder for solution for infusion | |||
Cilostazole | 100 mg x 28 tablets | MA and Dossier | ANTITHROMBOTIC PLASTIC ANTI-AGING |
Ciprofloxacin | 250 mg x 10 tablets | MA and Dossier | ANTIBACTERIALS FOR SYSTEMIC USE - KINOLONIC ANTIBACTERIALS |
500 mg x 6 tablets | |||
750 mg x 12 tablets | |||
Citalopram drops | 40 mg/ml | Dossier | ANTIDEPRESSANT -SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI) |
Clodronic Acid + lidocaine | 100 mg / 3,3 ml 6 vials | Dossier | FOR THE TREATMENT OF BONE DISEASE - BISPHOSPHONATE |
200 mg/ 4 ml 3 vials | |||
Dabigatran | 110 mg x 60 capsules | Under registration | ANTITHROMBOTIC AGENTS, DIRECT THROMBIN INHIBITORS |
110 mg x 30 capsules | |||
110 mg x 10 capsules | |||
150 mg x 60 capsules | |||
75 mg x 30 capsules | |||
75 mg x 10 capsules | |||
Desketoprofene | 25 mg 20 tablets | MA and Dossier | ANTI-INFLAMMATORY AND ANTIREHUMATIC, NOT STEROID |
25 mg oral solution stick pack | |||
Dutasteride | 0,5 mg x 30 capsules | MA and Dossier | DRUG USED IN BENIGNA PROSTATIC HYPERTROPHY |
Dutasteride and Tamsulosin | 0,5 mg/0,4 mg x 30 and 90 capsules | MA and Dossier | |
Escitalopram drops | 20 mg /ml - bottle 15 ml | MA and Dossier | ANTIDEPRESSANT - SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRI) |
Finasteride | 1 mg x 28 tablets | MA and Dossier | DRUG USED FOR STATES OF ANDROGENETIC ALOPECIA IN MEN |
5 mg x 15 tablets | DRUG USED IN BENIGNA PROSTATIC HYPERTROPHY | ||
Fosfomycin Trometamol | 3 g granular for solution - 2 sachets | MA and Dossier | ANTIBACTERIAL FOR SYSTEMIC USE |
Furosemide | 25 mg x 30 tablets | Dossier under submission | DIURETIC - DIURETIC FOR HIGHER DIURETIC ACTION - NON-ASSOCIATED SULPHONAMID |
Furosemide | 500 mg x 20 tablets | ||
Ibandronate | 150 mg x 3 tablets | MA and Dossier | FOR THE TREATMENT OF BONE DISEASE - BISPHOSPHONATE |
Manidipine | 10 mg x 28 tablets | MA and Dossier | CALCIUM-ANTAGONIST |
20 mg x 28 tablets | |||
Metformina | 500 mg, 30-50 tablets | MA and Dossier | FOR THE TREATMENT OF TYPE 2 DIABETES - BIGUANIDE |
850 mg, 30-40 tablets | |||
1000 mg, 60 tablets | |||
Nebivolole | 5 mg x 28 tablets | MA and Dossier | SELECTIVE BETA BLOCKER - FOR THE TREATMENT OF HYPERTENSION |
Omeprazole | 10 mg x 14-28 capsules | MA and Dossier | FOR DISORDERS RELATED TO ACID SECRETION - FOR THE TREATMENT OF PEPTIC ULCER AND GASTROESOGACEOUS REFLUX DISEASE - PROTON-PUMP INHIBITORS (PPIs) |
20 mg x 14-28 capsules | |||
40 mg x 14-28 capsules | |||
Pantoprazole (OTC) | 20 mg x 7 - 14 tablets | MA and Dossier | FOR DISORDERS RELATED TO ACID SECRETION - FOR THE TREATMENT OF PEPTIC ULCER AND GASTROESOGACEOUS REFLUX DISEASE - PROTON-PUMP INHIBITORS (PPIs) |
Paroxetine drops | 10 mg/ml oral drops, solution | MA end Dossier | ANTIDEPRESSANT -SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI) |
Prednisone | 5 mg x 20 tablets | MA and Dossier | SYSTEMIC CORTICOSTEROID - GLUCOCORTICOID |
5 mg x 10 tablets | |||
25 mg x 10 tablets | |||
Rivaroxaban | 10 mg x 30 film coated tablets | Under registration | ANTITHROMBOTIC DRUGS - DIRECT FACTOR XA INHIBITORS |
15 mg x 42 film coated tablets | |||
20 mg x 28 film coated tablets | |||
Sitagliptin | 25 mg x 28 film coated tablets | Under registration | ORAL HYPOGLYCEMIC AGENTS DRUGS USED IN DIABETES, DIPEPTIDYL PEPTIDASE 4 (DPP-4) INHIBITORS |
25 mg x 56 film coated tablets | |||
50 mg x 28 film coated tablets | |||
50 mg x 56 film coated tablets | |||
100 mg x 28 film coated tablets | |||
100 mg x 56 film coated tablets | |||
Sitagliptin + metformina | 50 mg + 850 mg x 56 film coated tablets | Under registration | DRUGS USED IN DIABETES, ORAL HYPOGLYCEMIC DRUG COMBINATIONS |
50 mg + 1000 mg x 56 film coated tablets | |||
Vildagliptin | 50 mg x 56 film coated tablets | Under registration | ORAL HYPOGLYCEMIC AGENTS DRUGS USED IN DIABETES, DIPEPTIDYL PEPTIDASE 4 (DPP-4) INHIBITORS |
50 mg x 28 film coated tablets | |||
Vildagliptin + metformina | 50 mg + 850 mg x 60 film coated tablets | Under registration | DRUGS USED IN DIABETES, ORAL HYPOGLYCEMIC DRUG COMBINATIONS |
50 mg + 1000 mg x 60 film coated tablets | |||
VITAMIN D3 | soft gel capsules: 10.000 U.I. | Dossier ready, MA under approval | VITAMIN D |
soft gel capsules: 25.000 U.I. | |||
soft gel capsules: 50.000 U.I. | |||
soft gel capsules: 100.000 U.I. | |||
injectable: 100.000 U.I. | |||
injectable: 300.000 U.I. | |||
Zolpidem | 10 mg/ml, oral drops, solution , bottle 30 ml | Under development | BENZODIAZEPINE-RELATED DRUGS |